OverviewChartNewsTraderScreen

HSBC TUR.WAR.OP.END. CPW/  DE000HG97QY9  /

gettex Zettex2
13/05/2024  21:35:41 Chg.-0.1200 Bid21:59:57 Ask21:59:57 Underlying Strike price Expiration date Option type
2.2800EUR -5.00% 2.2000
Bid Size: 30,000		 2.2200
Ask Size: 30,000		 Check Point Software... 127.3933 USD 31/12/2078 Call
GlobeNewswire 13/05 Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results
GlobeNewswire 13/05 DEADLINE ALERT for AVXL, HRT, and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 13/05 DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...
GlobeNewswire 13/05 CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire 13/05 Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire 13/05 Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire 13/05 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire 12/05 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...
GlobeNewswire 11/05 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counse...
GlobeNewswire 10/05 Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire 09/05 PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurre...
Newsfile Corp 09/05 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure ...
GlobeNewswire 09/05 Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sag...
GlobeNewswire 09/05 ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 09/05 Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 09/05 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire 08/05 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire 08/05 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
GlobeNewswire 08/05 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire 07/05 INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. ...
GlobeNewswire 07/05 ALX Oncology Appoints Allison Dillon as Chief Business Officer
GlobeNewswire 07/05 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...
GlobeNewswire 06/05 DEADLINE ALERT for IRBT, HRT, and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 06/05 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 06/05 DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...